Antabio to present at the 19th annual Superbugs & Superdrugs conference in London on March 21, 2017

Labège, 12th Jan 2017. Antabio announces that it will be presenting at the 19th annual Superbugs & Superdrugs conference in London (20th-21st March 2017)

Expanding horizons on the growing threat of anti-microbial resistance for almost two decades, this is the flagship show in the global Superbugs portfolio of events and will once again play host to an international audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities,

Martin Everett, CSO of Antabio, will be discussing the company’s metallo-β-lactamase inhibitor program in a presentation entitled “Fighting back against MBL mediated CREs: development of metallo-beta-lactamase inhibitors for use in combination with carbapenems”, Tuesday, March 21, 11.30.

 

For further details, click here: https://www.smi-online.co.uk/pharmaceuticals/uk/superbugs-superdrugs